Andrea Riccio spends much of her time researching Genomic imprinting, Genetics, DNA methylation, Molecular biology and Imprinting. She combines subjects such as Carcinogenesis, Beckwith–Wiedemann syndrome, Germline, Locus and Epigenetics with her study of Genomic imprinting. Her research integrates issues of Cancer research and Allele in her study of Beckwith–Wiedemann syndrome.
Her study in the field of Differentially methylated regions, Bisulfite sequencing, Epigenomics and Genetic marker is also linked to topics like Fibrinolytic agent. Her Molecular biology research is multidisciplinary, relying on both Sp3 transcription factor, Upstream Stimulatory Factor, Transcription factor, Biochemistry and Plasminogen activator. Her Imprinting study is concerned with the larger field of Gene.
Andrea Riccio mostly deals with Genetics, Genomic imprinting, DNA methylation, Imprinting and Beckwith–Wiedemann syndrome. Her studies in Genomic imprinting integrate themes in fields like KCNQ1OT1, Endocrinology, Gene duplication, Silver–Russell syndrome and Regulation of gene expression. In her study, which falls under the umbrella issue of DNA methylation, Penetrance is strongly linked to CTCF.
The Imprinting study which covers Insulin-like growth factor 2 that intersects with Cancer research. Her Beckwith–Wiedemann syndrome course of study focuses on Internal medicine and Genotype. Her Gene research focuses on subjects like Molecular biology, which are linked to Plasminogen activator, Urokinase, Cell culture, Transcription and Operon.
Andrea Riccio spends much of her time researching Genomic imprinting, Genetics, DNA methylation, Imprinting and Beckwith–Wiedemann syndrome. Her Genomic imprinting study incorporates themes from Bioinformatics, Chromosome, Allele, Regulation of gene expression and Epigenetics. Her work on Beckwith wiedemann as part of general Genetics study is frequently linked to Assisted reproductive technology, bridging the gap between disciplines.
Her DNA methylation research is under the purview of Gene. Her Imprinting research includes elements of Phenotype, Locus, Genetic counseling, Silver–Russell syndrome and Uniparental disomy. Her biological study deals with issues like Loss function, which deal with fields such as Pedigree chart.
Her primary scientific interests are in Beckwith–Wiedemann syndrome, Genetics, Epigenetics, Imprinting and Genomic imprinting. Her Beckwith–Wiedemann syndrome study combines topics from a wide range of disciplines, such as Increased risk, MEDLINE and Family medicine. DNA methylation, Copy-number variation, Locus and Genetic counseling are among the areas of Genetics where Andrea Riccio concentrates her study.
To a larger extent, Andrea Riccio studies Gene with the aim of understanding DNA methylation. Andrea Riccio interconnects Non-coding RNA, microRNA, Long non-coding RNA, Cell biology and Regulation of gene expression in the investigation of issues within Epigenetics. Her studies deal with areas such as MEG3 and Small nucleolar RNA as well as Genomic imprinting.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Plasminogen activator inhibitors: hormonally regulated serpins
Peter A. Andreasen;Birgitte Georg;Leif R. Lund;Andrea Riccio.
Molecular and Cellular Endocrinology (1990)
In embryonic stem cells, ZFP57/KAP1 recognize a methylated hexanucleotide to affect chromatin and DNA methylation of imprinting control regions.
Simon Quenneville;Gaetano Verde;Andrea Corsinotti;Adamandia Kapopoulou.
Molecular Cell (2011)
The H19 locus acts in vivo as a tumor suppressor.
Tomomi Yoshimizu;Audrey Miroglio;Marie-Anne Ripoche;Anne Gabory.
Proceedings of the National Academy of Sciences of the United States of America (2008)
Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome.
Wendy N Cooper;Anita Luharia;Gail A Evans;Hussain Raza.
European Journal of Human Genetics (2005)
Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome.
Angela Sparago;Flavia Cerrato;Maria Vernucci;Giovanni Battista Ferrero.
Nature Genetics (2004)
Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts.
L. R. Lund;A. Riccio;P. A. Andreasen;L. S. Nielsen.
The EMBO Journal (1987)
The human urokinase-plasminogen activator gene and its promoter
Andrea Riccio;Giovanna Grimaldi;Pasquale Verde;Gianfranco Sebastio.
Nucleic Acids Research (1985)
Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement.
Frédéric Brioude;Jennifer M Kalish;Alessandro Mussa;Alison C Foster;Alison C Foster.
Nature Reviews Endocrinology (2018)
Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing.
P.A. Andreasen;A. Riccio;K.G. Welinder;R. Douglas.
FEBS Letters (1986)
Hypomethylation at multiple maternally methylated imprinted regions including PLAGL1 and GNAS loci in Beckwith–Wiedemann syndrome
Jet Bliek;Gaetano Verde;Jonathan Callaway;Jonathan Callaway;Saskia M Maas.
European Journal of Human Genetics (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: